Prem Watsa · Q4 2016
Fairfax Financial Holdings
Portfolio at the end of Q4 2016, from the 13F filed February 13, 2017. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| BlackBerry BB · history | 27.5% | Q2 2013 or earlier | No change |
| Kennedy-Wilson KW · history | 21.6% | Q2 2013 or earlier | Add 38% |
| IBM IBM · history | 19.4% | Q2 2013 or earlier | No change |
| Resolute Forest Products RFP · history | 14.0% | Q2 2013 or earlier | No change |
| Beyond BYON · history | 4.8% | Q2 2013 or earlier | No change |
| Helmerich & Payne HP · history | 2.3% | Q1 2015 | No change |
| EXCO Resources XCO · history | 2.1% | Q2 2013 or earlier | Add 8% |
| U.S. Bancorp USB · history | 1.8% | Q2 2013 or earlier | Add 1659% |
| Johnson & Johnson JNJ · history | 1.5% | Q2 2013 or earlier | Add 83% |
| USG USG · history | 0.9% | Q2 2013 or earlier | Add 971% |
| POSCO Holdings PKX · history | 0.9% | Q3 2015 | No change |
| Protective Insurance BWINB · history | 0.8% | Q2 2013 or earlier | Reduce 61% |
| Jefferies Financial Group JEF · history | 0.6% | Q1 2016 | No change |
| Pfizer PFE · history | 0.6% | Q2 2013 or earlier | No change |
| Turquoise Hill Resources TRQ · history | 0.3% | Q4 2015 | No change |
| Wells Fargo WFC · history | 0.3% | Q2 2013 or earlier | Reduce 5% |
| Berkshire Hathaway BRK.B · history | 0.2% | Q2 2013 or earlier | Reduce 18% |
| Berkshire Hathaway BRK.A · history | 0.1% | Q2 2013 or earlier | No change |
| Monsanto MON · history | 0.1% | Q4 2016 | Buy |
| NetEase NTES · history | 0.1% | Q3 2016 | Add 200% |
| Valspar VAL.OLD · history | 0.1% | Q4 2016 | Buy |
| Stride LRN · history | 0.0% | Q3 2013 | No change |
| Rayonier Advanced Materials RYAM · history | 0.0% | Q3 2014 | Reduce 50% |
| New Oriental Education EDU · history | 0.0% | Q2 2013 or earlier | No change |
| Destination Maternity DEST · history | 0.0% | Q4 2016 | Buy |
| Enovis CFX · history | 0.0% | Q4 2015 | Reduce 39% |
| Team Health TMH · history | 0.0% | Q4 2016 | Buy |
| General Dynamics GD · history | 0.0% | Q2 2016 | No change |
| NOV NOV · history | 0.0% | Q2 2016 | No change |
| 29 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2016, adjusted for stock splits.
Sector weighting
| Technology | 46.9% | |
|---|---|---|
| Financials & real estate | 25.4% | |
| Materials | 16.2% | |
| Consumer discretionary | 4.9% | |
| Energy | 4.4% | |
| Health care | 2.1% | |
| Industrials | 0.0% |
What changed from Q3 2016
- Buy Monsanto MON 0.1% of the 13F
- Buy Valspar VAL.OLD 0.1% of the 13F
- Buy Destination Maternity DEST 0.0% of the 13F
- Buy Team Health TMH 0.0% of the 13F
- Add 38% Kennedy-Wilson KW 18.2% → 21.6%
- Add 8% EXCO Resources XCO 2.5% → 2.1%
- Add 1659% U.S. Bancorp USB 0.1% → 1.8%
- Add 83% Johnson & Johnson JNJ 0.9% → 1.5%
- Add 971% USG USG 0.1% → 0.9%
- Add 200% NetEase NTES 0.0% → 0.1%
- Reduce 61% Protective Insurance BWINB 2.2% → 0.8%
- Reduce 5% Wells Fargo WFC 0.3% → 0.3%
- Reduce 18% Berkshire Hathaway BRK.B 0.3% → 0.2%
- Reduce 50% Rayonier Advanced Materials RYAM 0.1% → 0.0%
- Reduce 39% Enovis CFX 0.0% → 0.0%
- Sell Lexmark LXK was 0.1%
- Sell Virgin America VA was 0.1%
- Sell Cvent CVT was 0.0%
- Sell CSX CSX was 0.0%